Hepatitis B Chronic Infection
Also known as: Hepatitis B, Chronic (CHB) / Hepatitis B, Chronic / Hepatitis B chronic / Hepatitis B, Chronic / Hepatitis B,Chronic / Chronic Hepatitis B / Chronic Hepatitis B Infection / Carrier of viral hepatitis B / Chronic type B viral hepatitis (disorder)
Drug | Drug Name | Drug Description |
---|---|---|
DB00718 | Adefovir dipivoxil | A nucleotide analog used to treat chronic hepatitis B. |
DB00442 | Entecavir | A nucleoside analogue used in the treatment of chronic hepatitis B for patients with active viral replication, histological evidence of active disease, or persistent elevations in liver transaminases. |
DB00034 | Interferon alfa-2a | A form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. |
DB00105 | Interferon alfa-2b | A form of recombinant human interferon used to treat hepatitis B and C infection, genital warts, hairy cell leukemia, follicular lymphoma, malignant melanoma, and AIDs-related Kaposi's sarcoma. |
DB00709 | Lamivudine | A reverse transcriptase inhibitor used to treat HIV and hepatitis B infections. |
DB00008 | Peginterferon alfa-2a | A modified form of recombinant human interferon used to stimulate the innate antiviral response in the treatment of hepatitis B and C viruses. |
DB01265 | Telbivudine | A thymidine nucleoside analog used for the treatment of chronic hepatitis B with clinical evidence of viral replication or persistent elevations in serum aminotransferases (ALT or AST). |
DB09299 | Tenofovir alafenamide | A nucleoside analog reverse transcriptase inhibitor used for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease. |
DB00300 | Tenofovir disoproxil | A nucleotide analog reverse transcriptase inhibitor used in the treatment of Hepatitis B infection and used in the management of HIV-1 infection. |
DB04900 | Thymalfasin | Indicated as an adjuvant for influenza vaccine in elderly patients and as an adjuvant for both influenza and hepatitis B vaccines in chronic hemodialysis patients who failed to achieve adequate... |